Baltimore Adopts Evolve™ Rodent Birth Control for Integrated Pest Management Targeting Rodent Overpopulation

Identifies Population Control as a Humane, Effective Solution for Winning the War Against Rats

PHOENIX, Jan. 21, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in innovative pest control solutions, is pleased to announce that the City of Baltimore has begun integrating Evolve™, SenesTech's cutting-edge rodent birth control product, into the city's rodent management programs. This marks a pivotal step in Baltimore's efforts to address its significant rodent population, a challenge highlighted by a recent ranking of Baltimore as one of America's "rattiest cities." The city has placed a substantial initial order for Evolve and plans to deploy the product this quarter as part of its integrated pest management (IPM) strategy.

Baltimore's Forward-Thinking Approach
Baltimore is taking proactive measures to reduce its rodent population in a sustainable, humane, and effective manner. Evolve targets the root cause of rodent infestations—reproduction. By restricting reproduction in both male and female rodents, Evolve offers a non-lethal solution that reduces the rodent population over time, complementing traditional pest management tools.

In a recent interview, Guy Bell, Chief of the Property Management Division at the Baltimore City Department of Public Works, emphasized the importance of this initiative: "If we can stop the rats from breeding, that will help us out." 

"Rodents pose a significant public health and infrastructure challenge, especially in urban centers like Baltimore," said Joel Fruendt, President and CEO of SenesTech. "We're excited to partner with Baltimore to implement Evolve in its pest control strategy. By addressing the reproductive rate, Evolve provides a lasting and humane solution to a persistent problem."

A Humane and Sustainable Solution
Unlike poisons or traps, which are often reactive and fail to address the root cause of rodent overpopulation, Evolve Rodent Birth Control works by reducing fertility rates. When incorporated into pest management programs, Evolve has been shown to significantly decrease rodent populations over time. Its EPA-designated "minimum risk" classification ensures that it is safe for people, pets, wildlife, and the environment.

The Baltimore Deployment
The City of Baltimore's decision to implement Evolve underscores its commitment to innovative and sustainable solutions for pest management. The initial deployment will focus on high-impact areas, with the goal of evaluating its effectiveness in reducing rodent populations while minimizing environmental and public health risks.

About SenesTech
SenesTech is committed to creating healthier environments by humanely managing animal pest populations through fertility control. The company's groundbreaking products, including Evolve™, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective, and sustainable.

For more information, visit https://senestech.com.

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that Baltimore's integration of Evolve into its pest management programs marks a pivotal step in Baltimore's efforts to address its significant rodent population; plans to deploy Evolve this quarter as part of Balitmore's integrated pest management strategy; our belief that Evolve provides a lasting and humane solution to a persistent problem; and Baltimore's initial deployment focus on high-impact areas with the goal of evaluating its effectiveness in reducing rodent populations while minimizing environmental and public health risks.

Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to maintain compliance with Nasdaq's continued listing requirements; regulatory approval and regulation of our products; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

Media Contact:

Rochelle Paulet
Director of Marketing
SenesTech, Inc.
(928) 779-4143 x814
[email protected]

Investor Relations Contact:

Robert Blum
Lytham Partners, LLC
(602) 889-9700
[email protected]

SOURCE SenesTech, Inc.